As of 2025-10-19, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is 1.51 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 16.88 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -91.4%.
The range of the Relative Valuation is (0.04) - 5.97 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.0x | 0.1x |
| Forward P/E multiples | 7.5x - 18.3x | 9.4x |
| Fair Price | (0.04) - 5.97 | 1.51 |
| Upside | -100.2% - -66.0% | -91.4% |
| Date | P/E |